NinePoint Medical has received $34 million in financing, which it will use to bring its NvisionVLE imaging system to market.
NvisionVLE allows physicians and pathologists to endoscopically view real-time, high-resolution, cross-sectional images of organs and tissues up to 3-mm deep at better than 10-micron resolution, according to the firm.
The financing was led by Corning, along with Third Rock Ventures and Prospect Venture Partners.
The company also added three new members to its board of directors: Curt Weinstein from Corning and independent directors Tom Miller and Mark Stautberg. Miller has previously held senior positions with Siemens Healthcare, Carl Zeiss, Analogic, and LightLab Imaging, while Stautberg brings experience from Boston Scientific and Baxter Healthcare.
